Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Other Non-Current Assets (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Other Non-Current Assets for 15 consecutive years, with $59.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Other Non-Current Assets changed N/A to $59.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was $59.7 million, a N/A change, with the full-year FY2024 number at $58.8 million, up 7.13% from a year prior.
  • Other Non-Current Assets was $59.7 million for Q3 2025 at Usana Health Sciences, down from $62.7 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $62.7 million in Q2 2025 to a low of $52.7 million in Q1 2024.
  • A 5-year average of $57.4 million and a median of $57.0 million in 2022 define the central range for Other Non-Current Assets.
  • Peak YoY movement for Other Non-Current Assets: soared 48.5% in 2021, then fell 7.15% in 2022.
  • Usana Health Sciences' Other Non-Current Assets stood at $56.3 million in 2021, then dropped by 2.63% to $54.8 million in 2022, then grew by 0.18% to $54.9 million in 2023, then rose by 7.13% to $58.8 million in 2024, then increased by 1.54% to $59.7 million in 2025.
  • Per Business Quant, the three most recent readings for USNA's Other Non-Current Assets are $59.7 million (Q3 2025), $62.7 million (Q2 2025), and $60.7 million (Q1 2025).